News tagged with nexavar
Sorafenib
Sorafenib (co-developed and co-marketed by Bayer and Onyx Pharmaceuticals as Nexavar), is a drug approved for the treatment of primary kidney cancer (advanced renal cell carcinoma) and advanced primary liver cancer (hepatocellular carcinoma).
For more information about Sorafenib, read the full article at
Wikipedia.
This text uses material from Wikipedia and is available under the GNU Free Documentation License.
British supermarket says to sell cancer drugs at cost
British supermarket chain Asda said on Thursday that it is to sell cancer drugs at cost-price and called on its peers who make massive profits on the treatments to follow suit.
Medicine & Health / Medications
May 20, 2010 |
5 / 5 (1) |
0
Drug for advanced kidney cancer shrinks tumors prior to surgery
More than 57,000 Americans face a diagnosis of kidney cancer each year. Now patients with advanced disease may soon have another treatment option. Physicians who conducted a pilot study at UNC Lineberger Comprehensive Cancer ...
Feb 17, 2010 |
1 / 5 (1) |
1
Growth factor hit by cancer drugs also protects heart
A growth factor that is a common target of cancer drugs also plays an important role in the heart's response to stress, researchers at The University of Texas M. D. Anderson Cancer Center report online this week in the Journal of ...
Medicine & Health / Medical research
Jan 11, 2010 |
not rated yet |
0
FDA questions safety of Glaxo kidney cancer drug
(AP) -- Federal regulators said Thursday an experimental kidney cancer drug from GlaxoSmithKline may cause liver problems, potentially outweighing its ability to slow the disease.
Medicine & Health / Medications
Oct 01, 2009 |
not rated yet |
0
Why Certain Cancer Treatments Cause High Blood Pressure
(PhysOrg.com) -- Drugs that block the formation of new blood vessels that feed tumor growth are helping some cancer patients enjoy longer lives.
Medicine & Health / Medications
Aug 04, 2009 |
not rated yet |
1
